Literature DB >> 15876373

Understanding carbamoyl phosphate synthetase deficiency: impact of clinical mutations on enzyme functionality.

Igor Yefimenko1, Vicente Fresquet, Clara Marco-Marín, Vicente Rubio, Javier Cervera.   

Abstract

Carbamoyl phosphate synthetase I (CPSI) deficiency, a recessively inherited error of the urea cycle, causes life-threatening hyperammonaemia. CPSI is a multidomain 1500-residue liver mitochondrial matrix protein that is allosterically activated by N-acetyl-l-glutamate, and which synthesises carbamoyl phosphate (CP) in three steps: bicarbonate phosphorylation by ATP, carbamate synthesis from carboxyphosphate and ammonia, and carbamate phosphorylation by ATP. Several missense mutations of CPSI have been reported in patients with CPSI deficiency, but the actual pathogenic potential and effects on the enzyme of these mutations remain non-characterised. Since the structure of Escherichia coli CPS is known and systems for its overexpression and purification are available, we have constructed and purified eight site-directed mutants of E.coli CPS affecting the enzyme large subunit (A126M, R169H, Q262P, N301K, P360L, V640R, R675L, S789P) that are homologous to corresponding missense mutations found in patients with CPSI deficiency, studying their stability and their ability to catalyse the CPS reaction as well as the partial reactions that reflect the different reactional steps, and analysing the substrate kinetics for the overall and partial reactions. The results show that all the mutations significantly decrease CP synthesis without completely inactivating the enzyme (as reflected in the catalysis of at least one partial reaction), that one of these mutations (Q262P) causes marked enzyme instability, and validate the use of E.coli CPS as a pathogenicity testing model for CPSI deficiency. The causality of the reported clinical mutations is supported and the derangements caused by the mutations are identified, revealing the specific roles of the residues that are mutated. In particular, the findings highlight the importance for carbamate phosphorylation and for allosteric activation of a loop that coordinates K(+), stress the key role of intersubunit interactions for CPS stability, and suggest that lid opening at both phosphorylation sites is concerted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876373     DOI: 10.1016/j.jmb.2005.03.078

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  Carbamoylphosphate synthetase 1 (CPS1) deficiency: clinical, biochemical, and molecular characterization in Malaysian patients.

Authors:  Ernie Zuraida Ali; Mohd Khairul Nizam Mohd Khalid; Zabedah Md Yunus; Yusnita Yakob; Chen Bee Chin; Kartikasalwah Abd Latif; Ngu Lock Hock
Journal:  Eur J Pediatr       Date:  2015-10-06       Impact factor: 3.183

2.  Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy.

Authors:  Xihui Chen; Lijuan Yuan; Mao Sun; Qingbo Liu; Yuanming Wu
Journal:  J Clin Lab Anal       Date:  2018-01-04       Impact factor: 2.352

3.  Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations.

Authors:  Johannes Häberle; Oleg A Shchelochkov; Jing Wang; Panagiotis Katsonis; Lynn Hall; Sara Reiss; Angela Eeds; Alecia Willis; Meeta Yadav; Samantha Summar; Olivier Lichtarge; Vicente Rubio; Lee-Jun Wong; Marshall Summar
Journal:  Hum Mutat       Date:  2011-05-05       Impact factor: 4.878

Review 4.  CPS1: Looking at an ancient enzyme in a modern light.

Authors:  Matthew Nitzahn; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2020-10-10       Impact factor: 4.797

5.  Enhanced production of L-arginine by improving carbamoyl phosphate supply in metabolically engineered Corynebacterium crenatum.

Authors:  Qing Wang; An Jiang; Jiabing Tang; Hui Gao; Xian Zhang; Taowei Yang; Zhenghong Xu; Meijuan Xu; Zhiming Rao
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-10       Impact factor: 4.813

6.  Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency.

Authors:  Keiji Kurokawa; Tohru Yorifuji; Masahiko Kawai; Toru Momoi; Hironori Nagasaka; Masaki Takayanagi; Keiko Kobayashi; Makoto Yoshino; Tomoki Kosho; Masanori Adachi; Harumi Otsuka; Shigenori Yamamoto; Toshiaki Murata; Akihito Suenaga; Tsutomu Ishii; Kihei Terada; Naoto Shimura; Kohji Kiwaki; Haruo Shintaku; Masaru Yamakawa; Hiroki Nakabayashi; Yosuke Wakutani; Tatsutoshi Nakahata
Journal:  J Hum Genet       Date:  2007-02-20       Impact factor: 3.172

7.  Zonal expression of hepatocytic marker enzymes during liver repopulation.

Authors:  Sarah Koenig; Hendryk Aurich; Christian Schneider; Petra Krause; Regine Haftendorn; Heinz Becker; Bruno Christ
Journal:  Histochem Cell Biol       Date:  2007-06-19       Impact factor: 4.304

8.  SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle.

Authors:  Takashi Nakagawa; David J Lomb; Marcia C Haigis; Leonard Guarente
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

9.  Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis.

Authors:  Sergio de Cima; Luis M Polo; Carmen Díez-Fernández; Ana I Martínez; Javier Cervera; Ignacio Fita; Vicente Rubio
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

10.  Quantitative proteomics of rat livers shows that unrestricted feeding is stressful for proteostasis with implications on life span.

Authors:  Galia Gat-Yablonski; Andrija Finka; Galit Pinto; Manfredo Quadroni; Biana Shtaif; Pierre Goloubinoff
Journal:  Aging (Albany NY)       Date:  2016-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.